Viokace (pancrelipase)

Manufacturer:
Aptalis Pharma
Route of Administration: 
Oral
Site of Care:
Outpatient
Website: 
    Enrollment Forms:
    Synergen Prescription Form

    Approved Indication:

    in combination with a proton pump inhibitor, for the treatment of exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatectomy in adults

    Conditions:

    • Exocrine Pancreatic Insufficiency

    Therapeutic Area:

    • Gastroenterology